Literature DB >> 20449867

Foxo1 regulates marginal zone B-cell development.

Jing Chen1, Jose J Limon, Caroline Blanc, Stanford L Peng, David A Fruman.   

Abstract

A fundamental component of signaling initiated by the BCR and CD19 is the activation of phosphoinositide 3-kinase. Downstream of phosphoinositide 3-kinase, the protein kinase AKT phosphorylates several substrates, including members of the forkhead box subgroup O (Foxo) transcription factor family. Among the Foxo proteins, Foxo1 has unique functions in bone marrow B-cell development and peripheral B-cell function. Here, we report a previously unrecognized role for Foxo1 in controlling the ratio of mature B-cell subsets in the spleen. Conditional deletion of Foxo1 in B cells resulted in an increased percentage of marginal zone B cells and a decrease in follicular (FO) B cells. In addition, Foxo1 deficiency corrected the absence of marginal zone B cells that occurs in CD19-deficient mice. These findings show that Foxo1 regulates the balance of mature B-cell subsets and is required for the marginal zone B-cell deficiency phenotype of mice lacking CD19.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20449867      PMCID: PMC2926184          DOI: 10.1002/eji.200939817

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-beta-directed IgA switching and changes in B cell fate.

Authors:  Jörg Klein; Wenjun Ju; Jörg Heyer; Britta Wittek; Torsten Haneke; Petra Knaus; Raju Kucherlapati; Erwin P Böttinger; Lars Nitschke; Burkhard Kneitz
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

Review 2.  Fine tuning the immune response with PI3K.

Authors:  David A Fruman; Georges Bismuth
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 3.  Peripheral B cell subsets.

Authors:  David Allman; Shiv Pillai
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

Review 4.  Foxo in the immune system.

Authors:  S L Peng
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

5.  Evidence of marginal-zone B cell-positive selection in spleen.

Authors:  Lijun Wen; Joni Brill-Dashoff; Susan A Shinton; Masanao Asano; Richard R Hardy; Kyoko Hayakawa
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

6.  Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

Authors:  Yann M Kerdiles; Daniel R Beisner; Roberto Tinoco; Anne S Dejean; Diego H Castrillon; Ronald A DePinho; Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-01-11       Impact factor: 25.606

7.  KLF4 is a FOXO target gene that suppresses B cell proliferation.

Authors:  Isharat Yusuf; Michael G Kharas; Jing Chen; Raechel Q Peralta; Autumn Maruniak; Pratibha Sareen; Vincent W Yang; Klaus H Kaestner; David A Fruman
Journal:  Int Immunol       Date:  2008-03-28       Impact factor: 4.823

8.  FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase.

Authors:  Stéphanie Fabre; Florent Carrette; Jing Chen; Valérie Lang; Monique Semichon; Christine Denoyelle; Vladimir Lazar; Nicolas Cagnard; Anne Dubart-Kupperschmitt; Marianne Mangeney; David A Fruman; Georges Bismuth
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.

Authors:  Linda V Sinclair; David Finlay; Carmen Feijoo; Georgina H Cornish; Alex Gray; Ann Ager; Klaus Okkenhaug; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2008-04-06       Impact factor: 25.606

10.  Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation.

Authors:  Hart S Dengler; Gisele V Baracho; Sidne A Omori; Shane Bruckner; Karen C Arden; Diego H Castrillon; Ronald A DePinho; Robert C Rickert
Journal:  Nat Immunol       Date:  2008-11-02       Impact factor: 25.606

View more
  20 in total

Review 1.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

Review 2.  FOXOs in cancer immunity: Knowns and unknowns.

Authors:  Youcai Deng; Fangjie Wang; Tiffany Hughes; Jianhua Yu
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

Review 3.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 4.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

5.  Induction of metabolic quiescence defines the transitional to follicular B cell switch.

Authors:  Jocelyn R Farmer; Hugues Allard-Chamard; Na Sun; Maimuna Ahmad; Alice Bertocchi; Vinay S Mahajan; Toby Aicher; Johan Arnold; Mark D Benson; Jordan Morningstar; Sara Barmettler; Grace Yuen; Samuel J H Murphy; Jolan E Walter; Musie Ghebremichael; Alex K Shalek; Facundo Batista; Robert Gerszten; Shiv Pillai
Journal:  Sci Signal       Date:  2019-10-22       Impact factor: 8.192

Review 6.  Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis.

Authors:  Adam S Lazorchak; Bing Su
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

Review 7.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

8.  Analysis of FOXO1 mutations in diffuse large B-cell lymphoma.

Authors:  Diane L Trinh; David W Scott; Ryan D Morin; Maria Mendez-Lago; Jianghong An; Steven J M Jones; Andrew J Mungall; Yongjun Zhao; Jacqueline Schein; Christian Steidl; Joseph M Connors; Randy D Gascoyne; Marco A Marra
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

9.  AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma.

Authors:  Timon A Bloedjes; Guus de Wilde; Chiel Maas; Eric Eldering; Richard J Bende; Carel J M van Noesel; Steven T Pals; Marcel Spaargaren; Jeroen E J Guikema
Journal:  Blood Adv       Date:  2020-09-08

10.  Akt and mTOR in B Cell Activation and Differentiation.

Authors:  Jose J Limon; David A Fruman
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.